Clinical Evaluation of HeartPoint Global Intellistent for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy
IntelliStent is intended to achieve reduction of pulmonary hypertension, improvements in symptoms and quality of life in pediatric, adolescent and adult patients with congenital heart disease associated pulmonary arterial hypertension or left ventricular dilated cardiomyopathy.
100 Clinical Results associated with Heartpoint Global Ltd.
0 Patents (Medical) associated with Heartpoint Global Ltd.
100 Deals associated with Heartpoint Global Ltd.
100 Translational Medicine associated with Heartpoint Global Ltd.